CCR4-351
Product Specifications
UNSPSC Description
CCR4-351 is an orally active, potent and selective CCR4 antagonist. CCR4-351, featuring a novel piperidinyl-azetidine motif, has IC50s of 22 nM and 50 nM in the calcium flux and CTX assay. CCR4-351 has antitumor activity[1].
Target Antigen
CCR
Type
Reference compound
Related Pathways
GPCR/G Protein;Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ccr4-351.html
Purity
98.95
Solubility
DMSO : 190 mg/mL (ultrasonic)
Smiles
[H][C@@]1(CCCN(C1)CCO)C2CN(C2)C3=CN=C(C4=N3)C(C#N)=NN4[C@H](C)C5=CC=C(C=C5Cl)Cl
Molecular Weight
500.42
References & Citations
[1]Omar Robles, et al. Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as Single Agent and in Combination with Checkpoint Inhibitors. J Med Chem. 2020 Jul 15.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-131349/CCR4-351-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-131349/CCR4-351-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2174938-70-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2058180-01 0.1 mL
Cy3-Linked Polyclonal Antibody to T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)
Ask
View Details MBS2058180-02 0.2 mL
Cy3-Linked Polyclonal Antibody to T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)
Ask
View Details MBS2058180-03 0.5 mL
Cy3-Linked Polyclonal Antibody to T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)
Ask
View Details